Assessment of non‐alcoholic fatty liver disease using serum total cell death and apoptosis markers

Abstract

Cytokeratin-18 M30 and M65/M65ED have moderate accuracy in detecting non-alcoholic steatohepatitis. Changes in the biomarkers also correlate with histological progression. However, development of new biomarkers is still required to improve the diagnostic accuracy.